Stand out for this role — generate a tailored resume and cover letter in about a minute.
Lilly's CMC group seeks an Associate Director of Drug Product to lead early-stage formulation development for small molecule neurotherapeutics, addressing narcolepsy and hypersomnia.
You will oversee nonclinical formulation programs, manage CROs/CDMOs, guide physiochemical characterization, design formulations (oral, subcutaneous, IV), and coordinate with discovery, clinical, and regulatory teams to prepare IND filings.
Associate Director of Drug Product in Lilly's CMC group, supporting early-stage development of small molecule neurotherapeutics targeting sleep-wake disorders, including narcolepsy and hypersomnia.
oversee nonclinical formulation development, manage CROs and CDMOs, guide physiochemical characterization, design formulations (oral, subcutaneous, IV), and support clinical formulation projects; collaborate across discovery, nonclinical, clinical, and regulatory teams; prepare regulatory documentation for IND submissions.
BS/MS in Pharmaceutical Sciences or related; 7+ years in small molecule formulation development, with experience supporting Phase I-III programs, expertise in poorly soluble compounds, and proficiency with analytical techniques (HPLC, XRPD, DSC, TGA, DVS). Preferred: PhD, strong project management, strategic problem-solving skills, and experience managing external vendors.
small molecule, early-phase clinical development, nonclinical and clinical formulation, cGMP knowledge, cross-functional collaboration.
US-based role with domestic and international travel (~5-10%).